Andere talen Cisen Pharmaceutical Co., Ltd.

Aandelen

603367

CNE100002VG4

slotkoers Shanghai S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
16,03 ^CNY	+1,20%		+0,94%	+9,49%

22/04	Cisen Pharmaceutical Co. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
2023	Cisen Pharmaceutical schrapt plan voor spin-off van eenheid	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cisen Pharmaceutical Names Chief Financial Officer	23/04
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Cisen Pharmaceutical Scraps Unit Spin-Off Plan	01/12
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) added to S&P Global BMI Index	18-09-23
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24-08-23
Cisen Pharmaceutical to Spin Off Unit for Shenzhen Float	09-06-23
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26-04-23
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	30-03-23
Cisen Pharmaceutical Secures Regulatory Approval for Methylcobalamin Tablets	22-11-22
Cisen Pharmaceutical Gets Regulatory Approval for Registration of Two Drugs	17-11-22
Cisen Pharma Gets Regulatory Nod For Flu Drug's China Clinical Trial	09-11-22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	17-10-22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26-04-22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25-03-22
Shijiazhuang No.4 Pharmaceutical Co., Ltd. completed the acquisition of 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke.	31-12-21
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) dropped from S&P Global BMI Index	20-12-21
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26-10-21
Sichuan Kelun Pharmaceutical Co., Ltd. completed the acquisition of 10% stake in Cisen Pharmaceutical Co., Ltd. from Tianjin Qianding Enterprise Management Partnership (Limited Partnership).	14-09-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cisen Pharmaceutical Co., Ltd.

Aandelen

603367

CNE100002VG4

Andere talen

Filters